Heterozygotes were considered as G6PD-normal patients on the assumption that type A-, a moderate G6PD deficiency (of class III), could barely trigger clinical manifestations if only a part of red blood cells was affected. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.